Basinang, Nikka Jane .

HRN: 21-47-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2022
CEFUROXIME 750MG (VIAL)
06/17/2022
06/24/2022
IV
150 Mg
Q8hrs
Acute Symptomatic Seiuzure, R/o Meningitis

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Non-compliant To Guidelines